Summary
Hepatitis B virus and the human immunodeficiency virus are similarly transmitted. Individuals with preexisting HIV infection have a higher chance to become HBsAg carriers than do anti-HIV negative persons. Cytotoxic T cells with specificity for HBcAg, that are under the control of HBcAg-specific helper T cells, are responsible for liver injury. There is good evidence that HIV infection lowers inflammatory activity, is associated with milder liver histology, high levels of viral replication and low seroconversion rates. In addition interferon alpha therapy is less effective in anti-HIV positive subjects. The immune response against HBsAg is helper T-cell dependent and vaccination against hepatitis B is of low effectiveness. In addition, vaccination against hepatitis B may activate the HIV disease and is, therefore, presently not to be recommended.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stevens CE, Taylor PE, Zang EA, Morrison JM, Harley EJ, DeCordoba R, Bacino S, Ting RCY, Bodner AJ, Sarngad-haran MG, Gallo RC, Rubinstein P (1986) Human T cell lymphotropic virus type III infection in a cohort of homosexual men in New York City. JAMA 255:2167–2172
Taylor PE, Stevens CE, DeCorboda SR, Rubinstein P (1988) Hepatitis B virus and human immunodeficiency virus: possible interactions. Viral hepatitis and liver disease. Liss, New York, pp 198–200
Polk BF, Fox R, Brookmeyer R, Kanchanaraksa S, Kaslow R, Visscher B, Rinaldo C, Phair J (1987) Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 316:61–66
Eddleston ALWF (1988) Immunological aspects of hepatitis B infection. Viral hepatitis and liver disease. Liss, New York, pp 603–605
Ferrari C, Penna A, Mondelli MU, Fiaccadori F, Chisari FV (1988) Intrahepatic, HBcAg specific regulatory T cell networks in chronic active hepatitis B. Viral hepatitis and liver disease, Liss, New York, pp 641–644
Milich DR, McLachlan A (1988) HBcAg can function both as a T cell independent and a T cell dependent antigen: HBcAg and HBeAg are cross-reactive at the T cell level. Viral hepatitis and liver disease. Liss, New York, pp 645–649
Celis E, Ou D, Otvos L Jr (1988) Identification of a major antigentic determinant of hepatitis B surface antigen for human T cell by means of synthetic peptides. Viral hepatitis and liver disease. Liss, New York, pp 650–655
Monno L, Angarano G, LoCaputo A, Casalino C, Carbonara S, Sanantonio T, Pollice L, Pastore G (1988) Unfavourable outcome of acute hepatitis B in anti-HIV positive drug addicts. Viral hepatitis and liver disease. Liss, New York, pp 205–206
Meuer SC, Moebius U, Manns M, Dienes HP, Ramadori G, Hess G, Hercend T, Meyer zum Büschenfelde KH (1988) Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. Eur J Immunol 18:1447–1452
Montano L, Miescher GC, Goodall AH et al (1982) Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection. Hepatology 2:557–561
Thomas HC (1988) Treatment of hepatitis B viral infection. Viral hepatitis and liver disease. Liss, New York, pp 817–822
Uy A, Bruß V, Gerlich WH et al (1989) Pre-core sequence of hepatitis B virus inducing e-antigen and membrane association of the viral core antigen. Virology (in press)
Hoofnagle JH (1982) Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bates ZB (1982) Seroconversion from hepatitis Be Antigen to antibody in chronic type B hepatitis. Ann Intern Med 94:744–748
Realdi G, Alberti A, Rugge M et al. (1983) Seroconversion from hepatitis Be antigen to anti-HBe in chronic type B virus infection. Gastroenterology 79:195–199
Rector WG Jr, Govindarajan S, Horsburgh CR jr, Penley KA, Cohn DL, Judson FN (1988) Hepatic inflammation, hepatitis B replication and cellular immune function in homosexual males with chronic hepatitis B and antibody to human immunodeficiency virus. Am J Gastroenterology 3:262–266
McDonald JA, Caruso L, Karayiannis P, Scully LJ, Harris JHW, Forster GE, Thomas HC (1987) Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha interferon. Hepatology 4:719–723
Hess G, Gerlich W, Weber C, Drees N, Meyer zum Büschenfelde KH (1987) Treatment of chronic type B hepatitis with recombinant leucocyte alpha A interferon: results of a phase II trial. Hepadna viruses. Liss, New York, pp 513–530
Hess G, Gerlich W, Slusarcyzk J, Hütteroth TH, Meyer zum Büschenfelde KH (1986) Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant leucocyte alpha a interferon. J Hepatol 3:245–251
Hess G, Rossol S, Voth R, Weber C, Drees N, Meyer zum Büschenfelde KH (1989) Treatment of protracted acute type B hepatitis with recombinant alpha a interferon: a pilot study. J Hepatol 8:73–76
Sen CG (1982) Mechanisms of interferon action: progress toward its understanding. In: Cohn WE (ed) Progress in nucleic acid research and molecular biology, vol 27, Academic Press, New York, pp 105–156
Paul RG, Roodman ST, Paul DA, Perillo RP (1988) Elevated HLA class I antigen expression on PBMC of HBV carriers with coexistent HIV infection. Viral hepatitis in liver disease. Liss, New York, pp 688–690
Loke RHT, Anderson MG, Tsiquaye KN, Coleman JC, Evans BA, Murray-Lyon IM, Zuckerman AJ (1988) Induced immunogenicity of recombinant yeast derived hepatitis B vaccines. Viral hepatitis and liver disease. Liss, New York, pp 1074–1075
Gesemann M, Scheiermann N, Brockmeyer N, Kreuzfelder E, Safary A, Simoen E, Hauser P, Andre F (1988) Clinical evaluation of a recombinant hepatitis B vaccine in HIV-infected vs uninfected persons. Viral hepatitis and liver disease. Liss, New York, pp 1076–1078
Hess G, Rossol S, Voth R, Cheatham-Speth D, Clemens R, Meyer zum Büschenfelde KH (in press) Active immunization of homosexual men using a recombinant hepatitis B vaccine. J Med Virol
Hadchouel M, Pasquinelli C, Fournier JG, Hugon RN, Scotto J, Bernard O, Brechot C (1988) Detection of mononuclear cells expressing hepatitis B virus in peripheral blood from HBsAg positive and negative patients by in situ hybridisation. J Med Virol 24:27–32
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hess, G., Rossol, S., Voth, R. et al. Modification of the immune response against hepatitis B virus by the human immunodeficiency virus. Rheumatol Int 9, 175–179 (1989). https://doi.org/10.1007/BF00271876
Issue Date:
DOI: https://doi.org/10.1007/BF00271876